Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123059) titled 'Intermittent Fasting for Fatty Liver Disease' on April 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First People's Hospital of Foshan
Condition:
Metabolic dysfunction-associated fatty liver disease
Intervention:
Semaglutide injection group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-22
Target Sample Size: Semaglutide injection group:50;5+2 Light Fasting group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=317617
Disclaimer: Curated by HT Syndication....